BONNEY MICHAEL W 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Aug 19, 2025
Insider Transaction Report
Form 4
BONNEY MICHAEL W
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-08-18−11,250→ 0 totalExercise: $70.20From: 2017-06-03Exp: 2026-06-03→ Common Stock (11,250 underlying) - Sale
Common Stock
2025-08-18$450.00/sh−11,250$5,062,500→ 16,804 total - Exercise/Conversion
Common Stock
2025-08-18$70.20/sh+11,250$789,750→ 28,054 total
Holdings
- 4,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024.
- [F2]The shares of ALNY common stock were purchased by the Michael W. Bonney Revocable Trust, of which the reporting person is trustee.
- [F3]The stock option was fully vested as of June 3, 2017.